I can’t quit figure out how to multi-quote so I’ll just try to answer some of the questions I’ve seen. I may be repeating myself because I don’t really have the time to re-read this entire thread.
Ive spoken to Dr M directly. He told me himself he has rat models that he hopes to be able to develop interventions for. Of course he didnt say these rat models have “PFS” but he did say that they have symptoms associated with PFS, so in that sense they have “PFS”. “Less mounting behavior, depressive tests, etc.” He said he had some ideas but did not elude. This was probably 14 months ago. He is focused in on 5ar genes. I mentioned multiple times that the AR gene also needs attention which he somewhat said “its possible” or something to that effect, but I think AXO also has stated that its a little frustrating he is so focused on only 5ar.
I probably don’t know more than what’s already been made public regarding Baylor. Other than the Foundation is getting pretty annoyed with them. Last I heard they were gathering data and the first of many studies was due… well its was probably 6 months ago now.
I’ve also spoken to Phil and Dr S each. Dr S told me a few years back that there was a company somewhat interested in an allpregnenlone drug to treat PFS… running a trial. He said at the time he didnt think it would do much and that we needed to see the study results otherwise we were throwing spaghetti at a wall that was 200 feet away.